Rainbow Childrens MedicareQ4 FY24

Rainbow Childrens Medicare Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,270.4P/E: 44.0Market Cap: ₹12.9K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Rainbow Children's Medicare expects mid-teen revenue growth (around 15-18%) in the coming years, maintaining disciplined growth aligned with top-line and bottom-line expansion.
  • Volume growth, particularly inpatient (IP) and outpatient (OP) volumes, is anticipated to improve following a muted previous year affected by seasonality and external factors like delayed monsoons and cyclones.
  • The company targets about 55% occupancy in FY25, signaling a return to normal seasonal patterns, which should boost volumes and revenues.
  • Deliveries grew by 7% last year, and fertility (IVF) services expansion is expected to contribute to growth, with IVF now offered in 11 centers versus three previously.
  • Insurance penetration is increasing, improving revenue quality, though ARPOB (average revenue per occupied bed) growth is expected to be flat or modest (+/- 1%) in FY25.
  • International business, currently ~3.4% of revenue, is targeted to grow to about 5% in FY25.

See what Rainbow Childrens Medicare management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • Rainbow Children's Medicare Limited currently has a robust net cash position of INR 515.9 crores as of March 31, 2024.
  • The company is confident of funding its ongoing and planned capital expenditure entirely through internal accruals.
  • There is no need for debt financing to support capital expenditures as per current cash flows and expected accruals.
  • No mention of any planned or ongoing fundraising through equity or debt was made during the call.
  • Management emphasized completing all planned capex through internal resources without incurring new debt.

See what Rainbow Childrens Medicare management said on order book — free account, 30 seconds.

Capex plans

Yes
  • The company is progressing on multiple new hospital projects:
  • - Spoke Hospital at Hennur, Bangalore (60 beds) and Rajahmundry, Andhra Pradesh (100 beds) expected to commence operations in Q4 FY25.
  • - Regional spoke hospital in Coimbatore project has begun, expected to complete in about 24 months.
  • - Land parcels in Gurgaon have been received possession letters; architectural designs are being finalized with groundbreaking expected in 3-4 months.
  • IVF services expansion:
  • - Increased from 3 to 11 centers providing IVF within existing hospitals.
  • - Capex for IVF centers estimated at INR 1.5-1.75 crore each, integrated within hospital development.
  • - Plans to add more IVF services in existing and upcoming hospitals.
  • For Q4 FY24, about INR 50 crores was invested in capital expenditure.
  • The company is confident of funding all ongoing and planned capex through internal accruals without debt financing.

Track Rainbow Childrens Medicare — get its next earnings analysis in your feed

How does Rainbow Childrens Medicare rank vs peers in Healthcare Services?

Pro feature
ThisRainbow Childrens Medicare
Rev 3Mar 3

How does Rainbow Childrens Medicare rank in Healthcare Services?

Compare Rainbow Childrens Medicare against every Healthcare Services company (Q4 FY24) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →